Alanine-Histidine-Lysine Copper Complex — Advanced copper-binding tripeptide for hair follicle, skin tissue, and angiogenesis research
Starter research supply — ideal for initial hair follicle or tissue remodeling studies
Extended supply for longitudinal angiogenesis and dermal remodeling research
High-volume research supply for comprehensive copper peptide study programs
Every AHK-Cu batch is HPLC analyzed for copper complex integrity and purity. Full COA with every order.
Premium copper tripeptide from $14.99 — unmatched value without compromising research quality.
Ships within 24–48 hours in discreet packaging. Tracked USA delivery standard.
Full COA confirming copper complex integrity, purity, and batch traceability included with every shipment.
| Peptide Name | AHK-Cu (Ala-His-Lys Copper Complex) |
| Sequence | Ala-His-Lys · Cu(II) |
| Molecular Formula | C₁₄H₂₂CuN₆O₄ |
| Molecular Weight | 401.91 g/mol |
| Purity | ≥99% (HPLC verified) |
| Form | Lyophilized powder (copper complex) |
| Storage | -20°C (long-term), 2–8°C (short-term) |
| Available Sizes | 50mg, 100mg, 200mg |
AHK-Cu is a copper-binding tripeptide studied for its roles in hair follicle biology, dermal fibroblast activity, angiogenesis, and tissue remodeling research. Copper peptides are a growing area of investigation in skin biology and regenerative research applications.
AHK-Cu (Ala-His-Lys) and GHK-Cu (Gly-His-Lys) are both copper tripeptides with overlapping research interests. AHK-Cu is specifically studied for hair follicle stimulation signaling pathways, while GHK-Cu has broader collagen synthesis and wound healing research applications.
Yes — AscendLabz provides AHK-Cu as a copper-chelated complex (Cu(II) bound form), verified by HPLC and mass spectrometry. Certificate of Analysis confirms complex formation and ≥99% purity.
AHK-Cu is a copper-binding tripeptide (Ala-His-Lys) with chelation affinity for divalent copper ions studied as part of the copper tripeptide / follicular research category. It is investigated in pre-clinical and in-vitro research models for its activity on follicular dermal papilla signaling and copper-dependent enzymatic pathways. The compound is supplied as a lyophilized powder of ≥99% HPLC-verified purity and is intended exclusively for laboratory research use under qualified scientific supervision.
AscendLabz AHK-Cu is sourced from cGMP-aligned synthesis facilities and validated for identity, purity, and counter-ion content prior to release. Each lot is independently tested by HPLC, and a Certificate of Analysis (COA) detailing peak area, retention time, and batch number is provided with every order. This level of documentation is intended to support reproducible research and clear chain-of-custody record-keeping in academic and independent laboratory environments.
For research workflows, AHK-Cu is most commonly characterized in cell-culture and isolated-tissue models where investigators examine copper coordination and tripeptide-receptor binding alongside complementary compounds in the copper peptide research compounds class. Reference standards and dose-response controls should be established by each laboratory prior to experimental use, and all material should be handled by trained personnel using appropriate personal protective equipment.
Storage: Lyophilized AHK-Cu is stable at -20°C protected from light. Reconstituted solutions should be refrigerated at 2-8°C and used within 30 days; avoid freeze-thaw cycles. Lyophilized peptides should be kept in original sealed packaging until use to prevent moisture uptake.
Reconstitution: Bring the lyophilized vial to room temperature before opening. Reconstitute with bacteriostatic water by injecting solvent down the inner wall of the vial; do not direct the stream onto the lyophilized cake. Gently swirl — do not vortex or shake — until fully dissolved. Allow 5-10 minutes for complete solvation.
Handling: Use sterile technique throughout. Wipe vial septa with isopropyl alcohol before each draw. Document reconstitution date, solvent volume, and resulting concentration on the vial label for traceability.
Every batch of AHK-Cu is analyzed by reverse-phase HPLC and confirmed to be ≥99% pure. Mass spectrometry confirms molecular identity, and counter-ion / residual-solvent panels are performed where applicable. The full Certificate of Analysis ships with each order and is also archived by lot number.
No. AHK-Cu is supplied strictly for in-vitro laboratory research and is not approved by the FDA, EMA, or any regulatory authority for human or veterinary therapeutic use. It must not be administered to humans or animals. By purchasing, you confirm you are a qualified researcher and the material will be used only in a controlled laboratory setting.
All orders ship from the USA via tracked courier within 24-48 hours of payment confirmation. Domestic delivery typically arrives within 2-5 business days in discreet, temperature-stable packaging. Tracking is provided by email at the time of dispatch.
AscendLabz prices AHK-Cu competitively while maintaining ≥99% HPLC-verified purity and a full COA. Bulk-vial bundles offer additional savings for laboratories ordering multi-month research supply. Pricing is reviewed monthly to remain among the most affordable verified-purity sources in the United States.
Cryptocurrency (Bitcoin, Ethereum, USDC, and others) is accepted with automatic discounts at checkout. Credit and debit cards are also supported through our secure payment processor. All transactions are encrypted end-to-end and order details are never shared with third parties.
Yes. Most laboratories order AHK-Cu together with complementary compounds from the copper peptide research compounds category. Combined orders ship together with a single COA package and qualify for bulk-tier pricing. See the related compounds section below for commonly paired research peptides.
Researchers ordering AHK-Cu frequently study it alongside these related compounds:
GHK-Cu · BPC-157 · TB-500 · Hyaluronic Acid
⚠️ Research Use Only
All products are strictly for laboratory research purposes only. Not for human consumption. AHK-Cu has not been approved by the FDA for therapeutic use. For in vitro research and scientific study only.